发明名称 |
Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration |
摘要 |
Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration. |
申请公布号 |
US9290464(B2) |
申请公布日期 |
2016.03.22 |
申请号 |
US201414337628 |
申请日期 |
2014.07.22 |
申请人 |
SK BIOPHARMACEUTICALS CO., LTD. |
发明人 |
Park Cheol Hyoung;Min Hye Kyung;Park In Suk;Lim Mi Jung;Lee Ji Won;Chung Jin Yong;Yoon Yeo Jin;Park Joo Young |
分类号 |
A61K31/42;A61K31/425;A61K31/41;C07D261/08;A61K31/4196;A61K31/4245;A61K31/433 |
主分类号 |
A61K31/42 |
代理机构 |
Harness, Dickey & Pierce, P.L.C. |
代理人 |
Harness, Dickey & Pierce, P.L.C. |
主权项 |
1. A method for treatment of a neurodegenerative disease, comprising:
administering to a subject in need of such treatment a therapeutically effective amount of a compound of Formula I, a pharmaceutically acceptable salt, an isomer, a solvate, or a hydrate thereof, or any combination thereof: wherein R is selected from the group consisting of substituted or unsubstituted C1-C15 arylalkyl, substituted or unsubstituted C1-C15 heteroarylalkyl, and substituted or unsubstituted, linear, branched or cyclic C1-C10 alkyl; Y is selected from the group consisting of O and —N—R1; R1 is at least one selected from the group consisting of —H and linear or branched C1-C3 alkyl; R2 is selected from the group consisting of —H and halo; A is selected from the group consisting of N, O, and S; B is C or N; Z is —OC(═O)NH2; m is an integer in the range of 0 to 4; and n is an integer in the range of 0 to 5. |
地址 |
Seoul KR |